ANLE138B Inhibitor

Name: ANLE138B Inhibitor; MyBioSource
Brand: MyBioSource
SKU: MBS5751848
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5751848

Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease More details

Please Inquire

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Anle138b, Inhibitor

Full Product Name

Anle138b

Product Gene Name

Anle138b, inhibitor

Form/Format

Powder

Purity/Purification

98.00%

Preparation and Storage

Store at -20 degree C for 3 years powder; -80 degree C for 2 years in solvent
For obtaining a higher solubility, please warm the tube at 37 degree C and shake it in the ultrasonic bath for a while. Stock solution can be stored below -20 degree C for several month.

Molecular Weight

343.17

Formula

C16H11BrN2O2

CAS

882697-00-9

Smiles

C1OC2=C(O1)C=C(C=C2)C3=CC(=NN3)C4=CC(=CC=C4)Br

Solubility

DMSO: 50mg/mL (145.70mM)
(<1mg/ml refers to the product slightly soluble or insoluble)

Product Categories/Family for Anle138b, inhibitor

Home; Others

Product References and Citations for Anle138b, inhibitor

1. Wagner J, et al. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. Acta Neuropathol. 2013 Jun;125 (6):795-813.

Other Notes

Small volumes of Anle138b, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Anle138b purchase

MBS5751848 is an inhibitor targeting Anle138b.